Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Aurobindo Pharma Limited
AUROPHARMAAurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India. Address: Galaxy, Plot No. 1, Hyderabad, India, 500032
Analytics
Preço Alvo de Wall Street
80 407.42 INRRácio P/E
23.2011Rendimento de dividendos
0.34 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave AUROPHARMA
Análise de Dividendos AUROPHARMA
Crescimento de dividendos em 5 anos
167 %Crescimento contínuo
–Taxa de pagamento em média de 5 anos
10 %Histórico de Dividendos AUROPHARMA
Avaliação de ações AUROPHARMA
Relatório AUROPHARMA
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |